BetterSeeds | Israeli Agritech Company at the Global Forefront — On Track for TSXV Listing
EXITEAM presents Investment Opportunity in BetterSeeds Ahead of TSXV Listing Starting from 100,000 ILS
Opportunity
Facilitated by
Pre-IPO Investment Opportunity · TSXV

Invest ahead of everyone in a company solving one of the world's greatest challenges

BetterSeeds — a pioneering Israeli biotech company in seed genetics. With an active commercial platform, existing revenues, and partnerships with industry giants — on track for listing on the Canadian stock exchange.

Opportunity to enter before the market
Before public exposure
Before everyone else
142 registered patents
$80B target market
World's first commercial application
EXITEAMPrivate Investor Inquiry

I want to learn more about this opportunity

An EXITEAM representative will contact you for a discreet introductory call regarding the BetterSeeds investment opportunity

Do you understand that the minimum investment amount is over 100,000 ILS?
Complete discretion · No obligation
The Current Situation

Not everything living on Earth is moving in the same direction

Over the next thirty years, the world will need to produce more food than ever before in history. The global population is growing rapidly, demand for food is rising, and the food industry is under unprecedented pressure.

Meanwhile, climate change is intensifying — droughts, heat waves, new pests, and diseases are decimating entire crops. The agricultural varieties feeding us today simply were not built for these conditions. They are collapsing in the face of changes happening too quickly.

The natural solution is to develop new, more resilient varieties. The problem: developing a new variety using traditional methods takes 10–15 years. We do not have that time. The world needs a solution now — not in a decade.

This is not just a crop problem. It is an existential challenge for the global food system — and whoever finds the solution will become a central part of one of the world's largest industries.

Global population is growing rapidly

Demand for food is rising

Climate change is intensifying

Existing varieties cannot cope with the changes

Developing new varieties takes many years

A gap threatening the global food system

How it works in practice

Two massive markets BetterSeeds is focusing on, suffering from the same problem

Not a theoretical discussion. Two products everyone knows — with real, urgent commercial and health problems that the market is seeking to solve.

Cacao
Cacao

The global cacao market faces an existential threat

  • Climate change is directly damaging crops
  • Approximately 40% of the crop is damaged by diseases and pests
  • 5.5 million cacao farmers at risk
  • Many farmers are abandoning cacao cultivation
  • Cacao prices are breaking records
Without a solution, by 2050 there will be no chocolate industry
Peanuts
Peanuts

A cheap and healthy protein source — blocked for millions

  • One of the world's cheapest and healthiest protein sources
  • But unsuitable for everyone due to allergies
  • 6.1 million Americans are allergic to peanuts
  • Peanuts banned from kindergartens and schools
  • Many public spaces in the U.S. are peanut-free zones
A massive market with no existing solution
The Solution

Plant genome editing — the solution for seed companies

Genome editing enables targeted and precise changes to a plant's DNA, thereby developing new traits that address exactly the problems the market struggles with — without waiting through long years of traditional development.

Targeted and precise changes to plant DNA

Climate resilience

Disease and pest resistance

Nutritional improvement

Allergen reduction

So how does it work

CRISPR — the "molecular scissors" transforming the agricultural world

CRISPR is a genetic editing technology that enables cutting DNA at a specific and precise location, thereby creating a desired new trait in the plant. The plant grows with the new trait — and passes it on to its offspring.

However, its existing version — Generation 1 CRISPR — operates inefficiently and does not actually solve the problem for the seed industry.

The technology won the
Nobel Prize in Chemistry
2020
The Existing Solution

Generation 1 CRISPR

  • An inefficient solution for the seed industry
  • High development costs
  • Developing a new variety takes 3–4 years
  • Applicable to only a few crop types
  • Most companies lack suitable traits
The Turning Point

Generation 2 CRISPR — BetterSeeds' Solution

  • A complete platform — not a single component
  • At least 50% savings in price and costs
  • At least 50% savings in development time
  • Suitable for most crop types
  • Active and proven technology — not a theoretical concept
What BetterSeeds did differently

Not a single component — a complete platform

Three components working together, enabling rapid, cost-effective, and efficient application of genome editing across a wide range of crops.

CRISPR

Miniaturized Gen 2
The genetic editing engine

An advanced and miniaturized version of CRISPR, adapted for efficient and large-scale application in plants.

EDGE

Viral delivery system
Solving the bottleneck

A delivery system that transfers the genetic edit into the plant — the point where the entire industry has been stuck for years.

Traits

Genetic trait library
Ready-to-use library

A library of climate-resilient genetic traits — that can be immediately applied to different crops.

A complete end-to-end solution — not just technology, but an entire system that shortens timelines, reduces costs, and enables commercialization.

Why it's better

The numbers making BetterSeeds the next industry standard

50%+
Savings in price and development costs
50%+
Savings in new variety development time
1
One platform for the entire crop and seed portfolio
Suitable for most crop types
It's already working

Not theory. Real commercial applications in the field.

Allergen-reduced peanuts
Allergen-reduced peanuts
World's first commercial application

The world's first allergen-reduced peanuts

Addressing 6.1 million people in the U.S. alone

Agrinetica
Developed by subsidiary Agrinetica
  • Precedent-setting USDA approval for gene-edited peanuts
  • Allergen-reduced peanut butter on shelves — 2027
  • Commercial agreement and ownership partnership with Hardcore Peanuts Butter
Cacao
Advanced Development Stage

Addressing climate change and high caffeine concentration issues

The Solution to the Global Cocoa Crisis

Agronetica
Developed by subsidiary Agrinetica
  • Addressing the climate change problem in cacao cultivation
  • Reducing high caffeine concentration in chocolate
  • The answer to a problem threatening to eliminate the global chocolate industry
Cacao
Beans
Beans · Black Eyed Peas
Ready for commercial stage

Affordable alternative protein for the food industry

Developed, proven, and ready for commercial stage

  • Plant-based alternative protein for the global food industry
  • Significantly cheaper than soy protein
  • Developed, proven, and ready for commercial stage
  • Addressing growing demand for plant-based proteins
Validation and intellectual property

Partnerships with key global players

Industry validation

Syngenta
Additional Companies (Confidential)

Academic validation

The Hebrew University of Jerusalem
Tel Aviv University
Volcani Institute — Agricultural Research Center
Vilnius University, Lithuania
CPSBB — European Institute for Plant Sciences
142
Patents protecting the platform

Intellectual property covering every component of the solution

Small Gen 2 CRISPR
EDGE system
Range of genetic traits
Work processes and implementation
Market size

An $80 billion market seeking a solution

$80B
Global seed market
$12B
Gene-edited seed market
6.6%
Annual market growth
Thousands
Potential seed companies
Competitive landscape

Leading companies in the field — where BetterSeeds is positioned

All the world's leading companies in plant gene editing operate on Generation 1 CRISPR, with limited and specific applications. BetterSeeds is the only company with a complete Generation 2 platform.

Company
innovative
Crop
Latest Funding
Revenue
Estimated Valuation
BetterSeeds
Proprietary 2nd-Gen CRISPR
Complete Platform — Cocoa, Peanuts, Beans, and More
Fundraising Stage
Existing Revenue
To Be Disclosed at IPO
Inari
1st-Gen CRISPR (Licensed)
Drought Resistance and Yield Enhancement in Corn, Wheat, Soy
$720M (2025)
No Revenue
$2.2B
Pairwise
1st-Gen CRISPR (Licensed)
Seedless Raspberries, Non-Pungent Mustard
$155M
Symbolic
~$500M
Ohalo
Proprietary Non-CRISPR
Almonds, Strawberries
$210M (2025)
No Revenue
$1–2B
Markets value competitors at $500M to $2.2B — despite operating with less efficient technology.

*In the absence of public information, all data is estimated by the company.

Management and team

The team building the next industry standard

Behind BetterSeeds stands a serious scientific team — most employees are scientists and researchers with deep academic backgrounds in biology, genetics, and plant sciences.

Ido Margalit

Ido Margalit

Founder and CEO

27 years of experience as a senior executive in the agritech industry. Former Business Development Manager at Syngenta. Second-time entrepreneur.

Dr. Tal Sherman

Dr. Tal Sherman

Founder and CTO

12 years of experience in plant breeding and R Former Traits Project Leader at Syngenta.

Dr. Helmut Schramm

Dr. Helmut Schramm

Chairman

Former President of Bayer CropScience and CEO of Bayer CS Germany.

Dr. Shira Corem

Dr. Shira Corem

VP RD

15 years of experience in plant research management and genome editing.

Ilanit Madari

Ilanit Madari

CFO

28 years of experience in financial management at numerous startups.

Rami Dar

Rami Dar

Director

Former CEO of Hazera (Limagrain Group) — Israel's largest seed company, and former Chairman of Novalog.

19
Full-time employees
Including 14 scientists and researchers
1,600 sqm
Laboratories and cultivation facilities
Advanced laboratories, climate-controlled cultivation facilities, and offices
4 dunams
Experimental farm
Greenhouses and trial areas — full capability from laboratory to field and commercialization
Why now

Right timing — before the standard changes

The technology is proven and ready for commercial licensing — not futuristic RD
Accelerating global demand from the seed and food industries
Partnerships with Key Players — Syngenta and Other Companies
Allergen-reduced peanut butter on shelves in 2027
The company is on track for listing on the Canadian TSXV exchange

BetterSeeds is a complete end-to-end platform for plant genome editing, with commercial proof, a business model, and a massive market.

Today — an early opportunity.
Tomorrow — an industry standard.

Facilitated byEXITEAM

How the investment is made through EXITEAM

EXITEAM specializes in guiding Israeli technology companies toward listing on the Canadian stock exchange, and presents select investment opportunities to relevant investors before the public stage.

1

Selection and guidance of BetterSeeds

EXITEAM selected BetterSeeds as a company with unique technology, a significant market, and growth potential ahead of listing.

2

Establishment of a dedicated Canadian acquisition corporation

The investment structure is established as part of the process toward listing on TSXV.

3

Presenting the opportunity to investors

EXITEAM presents the opportunity to relevant investors in Israel and Canada — not to the general public.

4

Investment in the dedicated corporation

75% of investment funds are held in trust until the company is listed for trading.

5

Listing on the Canadian stock exchange

BetterSeeds is listed on TSXV through a merger with the dedicated acquisition corporation.

6

Tradable shares

Upon listing, the holdings become tradable according to the transaction structure.

Private Investor Inquiry

Investment eligibility check for BetterSeeds through EXITEAM

Leave your details and an EXITEAM representative will contact you for a discreet introductory call regarding the opportunity. The call is intended for those interested in investing NIS 100,000 or more.

EXITEAMSubmit details
Do you understand that the minimum investment amount is over 100,000 ILS?
Complete discretion · No obligation · Intended for relevant investors only
BetterSeeds
EXITEAM

Israeli agritech company at the global forefront · Facilitated by EXITEAM

Nothing stated herein constitutes a guarantee of any return. Investing in a private or pre-public company involves significant risks, including total loss of investment. Nothing stated herein constitutes investment advice, tax advice, or legal advice. The information presented is based on public sources and information published by the company and the facilitating entity, and does not necessarily represent the most current status. Any investment decision should be made after independent review and consultation with appropriate professionals. EXITEAM acts as an intermediary and does not provide investment advice.
© 2025 BetterSeeds · EXITEAM. All rights reserved.